Thermo Fisher Scientific Inc.
TMO· NYSE
TMOThermo Fisher Scientific Inc.
Filed Feb 26, 2020 · 10-K · 57 days after period end · 0000097745-20-000009
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Revenue | $6.83B | $6.51B | $6.05B | $4.95B |
| EPS Diluted | $2.49 | $2.22 | $1.30 | $1.59 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Feb 26, 2020 · 57 d after period end
